News

The Latest Industry News

Texas Diabetes & Endocrinology Partners with MyDiabetesHome

Posted on November 11, 2016

Texas Diabetes & Endocrinology is proud to announce our new partnership with MyDiabetesHome.  MyDiabetesHome.com is a personalized diabetes management platform providing diabetic patients with tools to track  blood sugar and manage medications. The interactive dashboard is easily accessible via computer, tablet or mobile device and allows patients to simplify their life, drastically improve doctor visits, […]

Read More

FDA approves first automated insulin-delivery device for type 1 diabetes

Posted on October 7, 2016

The FDA announced the approval of Medtronic’s MiniMed 670G, the first hybrid closed loop system – often referred to as an “artificial pancreas” – on September 28th. The device is designed to check sugar levels, and provide appropriate insulin doses, based on those readings. It is currently approved for use for people aged 14 years and […]

Read More

New Postmenopausal Osteoporosis Guidelines

Posted on September 30, 2016

The American Association of Clinical Endocrinologists (AACE) has updated its postmenopausal osteoporosis guidelines. The new guidelines cover risk factors and fall prevention measures in more detail than prior guidelines. Pharmacological treatment is recommended for patients with osteoporosis, patients with osteopenia who have had a fragility fracture of the hip or spine, and for patients with […]

Read More

Kerem Ozer, MD inducted as a Fellow of the American College of Endocrinology

Posted on July 26, 2016

The American College of Endocrinology (ACE), the educational and research arm of the American Association of Clinical Endocrinologists (AACE), inducted Dr. Kerem Ozer, Texas Diabetes & Endocrinology physician partner, as a Fellow of the American College of Endocrinology during its recent convocation ceremony at the 2016 AACE Annual Meeting and Clinical Congress in Orlando, Florida. […]

Read More

Statins & Diabetes

Posted on July 14, 2016

Despite great strides in health care, heart disease remains the number one cause of death in the United States. Individuals with diabetes are three times more likely to develop heart disease, heart attack or stroke than someone without diabetes. We at TDE take this very seriously and work with our patients to reduce their cardiac […]

Read More

Study published in JAMA Network by Lindsay Harrison, MD

Posted on June 13, 2016

Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial Liraglutide added to high-dose insulin therapy improved glycemic control, decreased body weight, and enhanced treatment satisfaction in this difficult-to-treat patient population with high-dose insulin requirements. Further studies are warranted to confirm these findings and […]

Read More

Benefits of Continuous Glucose Monitors (CGMs)

Posted on May 25, 2016

Achieving your target hemoglobin A1C when you have diabetes can be difficult, and even more so if you have a fear of hypoglycemia (low blood glucose), as many do. The natural reaction is to allow blood sugar levels to remain high in order to prevent low glucose episodes. However, in the long run, we know […]

Read More

First Pediatric Research Trial – Faster Acting Meal Time Insulin

Posted on May 3, 2016

READY. SET. GO!!! Texas Diabetes & Endocrinology (TDE) announced today they are scheduling for the first, of a series of several, pediatric/teen research trials. This first study will be researching an investigational faster acting meal time insulin in children ages 10 to 17 years of age who are currently on multiple daily injections of insulin. […]

Read More

Intensive Lifestyle Intervention Improves Metabolism and Bone Strength

Posted on April 19, 2016

Older adults with obesity and type 2 diabetes saw improved glucose control, body composition, physical function, and bone quality when assigned to an intensive diet and exercise program. Preliminary results from an ongoing trial at the Baylor College of Medicine in Houston were just presented at the Endocrine Society Annual Meeting in Boston. Investigators looked […]

Read More

First Pediatric Research Trial Begins May 1, 2016

Posted on April 1, 2016

Time to jump in!!! On May 1st, Texas Diabetes & Endocrinology will be initiating the first, of a series of several, pediatric/teen research trials. This first study will be researching an investigational faster acting meal time insulin in children ages 10 to 17 years of age who are currently on multiple daily injections of insulin. […]

Read More